Abstract
Preliminary data suggest that all-cause mortality is increased among individuals who are treated with growth hormone for childhood short stature. However, causality can not be determined due to the preliminary nature of the results, as well as a low event rate, limited power, and potentially undefined confounders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
